Pfizer-BioNTech launches clinical trial of vaccine against Omicron
(Washington) The Pfizer-BioNTech alliance has started recruiting for a clinical trial which aims to test, on adults aged 55 and under, the safety and immune response of their vaccine against COVID-19 which specifically targets the variant Omicron, the two companies announced on Tuesday.
Posted at 6:49 a.m.
The boss of the American laboratory Pfizer, Albert Bourla, said in early January that the pharmaceutical giant could be ready to request authorizations for the new vaccine, which targets this variant of COVID-19, as early as March.
While current data indic...